Repare Therapeutics (RPTX) Short Interest Ratio & Short Volume $1.66 +0.01 (+0.61%) Closing price 04:00 PM EasternExtended Trading$1.64 -0.01 (-0.90%) As of 06:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Repare Therapeutics Short Interest DataRepare Therapeutics (RPTX) has a short interest of 685,500 shares, representing 2.23% of the float (the number of shares available for trading by the public). This marks a 22.11% increase in short interest from the previous month. The short interest ratio (days to cover) is 2.3, indicating that it would take 2.3 days of the average trading volume of 90,654 shares to cover all short positions.Current Short Interest685,500 sharesPrevious Short Interest561,400 sharesChange Vs. Previous Month+22.11%Dollar Volume Sold Short$1.04 millionShort Interest Ratio2.3 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares42,960,000 sharesFloat Size30,770,000 sharesShort Percent of Float2.23%Today's Trading Volume46,019 sharesAverage Trading Volume90,654 sharesToday's Volume Vs. Average51% Short Selling Repare Therapeutics? Sign up to receive the latest short interest report for Repare Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRPTX Short Interest Over TimeRPTX Days to Cover Over TimeRPTX Percentage of Float Shorted Over Time Repare Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/2025685,500 shares $1.04 million +22.1%2.2%2.3 $1.51 7/15/2025561,400 shares $802.80 thousand -11.0%1.8%1.6 $1.43 6/30/2025631,000 shares $877.09 thousand +6.3%2.1%2.5 $1.39 6/15/2025593,500 shares $870.66 thousand +5.6%1.9%2.1 $1.47 5/31/2025562,100 shares $781.32 thousand +1.3%1.8%1.9 $1.39 5/15/2025555,100 shares $738.28 thousand +9.0%1.8%1.8 $1.33 4/30/2025509,200 shares $697.60 thousand -26.7%1.7%1.7 $1.37 4/15/2025694,200 shares $763.62 thousand -12.8%2.3%2.3 $1.10 3/31/2025795,900 shares $784.68 thousand -20.4%2.6%3 $0.99 3/15/20251,000,000 shares $1.10 million -5.7%3.3%3 $1.10 Get the Latest News and Ratings for RPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,060,000 shares $1.25 million -1.9%3.5%2.3 $1.18 2/15/20251,080,000 shares $1.37 million +0.9%3.5%2.4 $1.27 1/31/20251,070,000 shares $1.31 million -5.3%3.5%2.4 $1.22 1/15/20251,130,000 shares $1.45 million -13.1%3.7%2.7 $1.28 12/31/20241,300,000 shares $1.70 million +53.3%4.3%3.4 $1.31 12/15/2024847,800 shares $1.50 million +47.1%2.9%2.8 $1.77 11/30/2024576,500 shares $1.89 million -5.5%2.0%4.6 $3.28 11/15/2024609,900 shares $1.90 million -18.7%2.1%5.3 $3.11 10/31/2024749,700 shares $2.51 million +4.6%2.6%7.3 $3.35 10/15/2024717,000 shares $2.41 million +0.7%2.5%6.8 $3.36 9/30/2024712,300 shares $2.45 million -3.6%2.5%5.8 $3.44 9/15/2024738,900 shares $2.61 million +2.4%2.6%6.3 $3.53 8/31/2024721,300 shares $2.10 million -2.8%2.5%6.1 $2.91 8/15/2024741,700 shares $2.23 million -0.8%2.6%5.2 $3.00 7/31/2024747,500 shares $2.80 million -16.9%2.6%3 $3.74 7/15/2024900,000 shares $3.24 million +4.0%3.1%3.6 $3.60 6/30/2024865,200 shares $2.86 million +51.1%3.0%3.6 $3.30 6/15/2024572,600 shares $2.18 million +17.8%2.0%2.3 $3.80 5/31/2024485,900 shares $1.69 million -7.3%1.7%2.1 $3.48 5/15/2024524,300 shares $1.87 million -23.2%1.8%2.5 $3.57 4/30/2024682,500 shares $2.12 million +12.2%2.4%3.5 $3.10 4/15/2024608,300 shares $2.11 million -10.7%2.1%4.7 $3.47 3/31/2024681,000 shares $3.21 million +3.4%2.4%4.6 $4.71 3/15/2024658,600 shares $3.48 million -11.4%2.3%4.2 $5.29 2/29/2024743,300 shares $5.17 million -8.5%2.6%3.7 $6.95 2/15/2024812,500 shares $5.65 million -52.8%2.8%3.6 $6.95 1/31/20241,720,000 shares $11.25 million -20.0%5.4%5.7 $6.54 1/15/20242,150,000 shares $14.06 million -2.7%6.8%6 $6.54 12/31/20232,210,000 shares $16.13 million -12.3%7.0%5.9 $7.30 12/15/20232,520,000 shares $17.01 million -7.4%7.9%6.9 $6.75Musk’s Project Colossus could mint millionaires (Ad)I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.All the details are waiting for you now — but you need to act before the September 1st funding windo 11/30/20232,720,000 shares $14.01 million +25.9%8.6%7.8 $5.15 11/15/20232,160,000 shares $11.43 million +24.1%6.8%6.9 $5.29 10/31/20231,740,000 shares $5.92 million +10.8%5.5%7.4 $3.40 10/15/20231,570,000 shares $8.29 million +23.6%4.9%9.9 $5.28 9/30/20231,270,000 shares $15.34 million +1.6%4.0%10.8 $12.08 9/15/20231,250,000 shares $12.90 million +4.2%3.9%12.3 $10.32 8/31/20231,200,000 shares $11.71 million -3.2%3.8%12.5 $9.76 8/15/20231,240,000 shares $12.05 million +0.8%3.9%12.1 $9.72 7/31/20231,230,000 shares $11.32 million -5.4%3.9%12.6 $9.20 7/15/20231,300,000 shares $14.14 million +2.4%4.1%13.7 $10.88 6/30/20231,270,000 shares $13.44 million -5.9%4.0%12.4 $10.58 6/15/20231,350,000 shares $16.67 million +7.1%4.3%13 $12.35 5/31/20231,260,000 shares $13.37 million -2.3%4.0%12.2 $10.61 5/15/20231,290,000 shares $13.08 million -4.4%4.1%12.8 $10.14 4/30/20231,350,000 shares $12.10 million -12.9%4.3%12 $8.96 4/15/20231,550,000 shares $14.06 million -8.3%5.0%12.6 $9.07 3/31/20231,690,000 shares $16.63 million +1.2%5.4%13.4 $9.84 3/15/20231,670,000 shares $16.60 million +6.4%5.4%11.6 $9.94 2/28/20231,570,000 shares $16.09 million +4.0%5.1%9.7 $10.25 2/15/20231,510,000 shares $17.41 million +4.9%4.9%9.2 $11.53 1/31/20231,440,000 shares $17.80 million -7.1%4.7%7.7 $12.36 1/15/20231,550,000 shares $19.92 million +22.1%5.0%8.8 $12.85 12/30/20221,270,000 shares $18.68 million +64.2%4.1%7.5 $14.71 12/15/2022773,300 shares $11.55 million -39.6%2.5%4.9 $14.93 11/30/20221,280,000 shares $20.52 million -18.0%4.2%8.9 $16.03 11/15/20221,560,000 shares $26.69 million +0.7%5.1%11.7 $17.11 10/31/20221,550,000 shares $23.34 million -1.9%5.1%12.6 $15.06 10/15/20221,580,000 shares $21.09 million -1.9%5.2%10.8 $13.35 9/30/20221,610,000 shares $19.53 million +4.6%5.3%10.5 $12.13 9/15/20221,540,000 shares $20.14 million -4.4%5.0%9.1 $13.08 8/31/20221,610,000 shares $19.19 million +5.2%5.3%7.9 $11.92 8/15/20221,530,000 shares $18.74 million -26.1%5.0%1.8 $12.25 7/31/20222,070,000 shares $26.16 million -1.0%6.8%2.5 $12.64 7/15/20222,090,000 shares $30.45 million +2.0%6.8%2.5 $14.57 6/30/20222,050,000 shares $28.68 million -15.6%6.7%2.4 $13.99 6/15/20222,430,000 shares $32.73 million +30.7%8.0%2.9 $13.47 5/31/20221,860,000 shares $17.07 million -4.6%6.4%2.3 $9.18 5/15/20221,950,000 shares $17.08 million -24.7%6.7%11.6 $8.76 4/30/20222,590,000 shares $28.49 million -12.8%8.9%15.8 $11.00 4/15/20222,970,000 shares $34.07 million +0.3%10.2%17.1 $11.47 3/31/20222,960,000 shares $42.15 million +6.1%10.2%17.2 $14.24 3/15/20222,790,000 shares $33.81 million -0.4%9.6%16.7 $12.12 2/28/20222,800,000 shares $45.00 million +3.7%9.7%16.3 $16.07 2/15/20222,700,000 shares $40.37 million +1.9%9.4%14.7 $14.95 1/31/20222,650,000 shares $40.89 million +4.3%9.1%14.9 $15.43 1/15/20222,540,000 shares $38.68 million +2.0%8.8%13.1 $15.23 12/31/20212,490,000 shares $52.51 million -2.7%9.8%12.3 $21.09 12/15/20212,560,000 shares $52.86 million +4.1%10.1%10.4 $20.65 11/30/20212,460,000 shares $57.74 million +6.0%9.8%9.8 $23.47 11/15/20212,320,000 shares $62.73 million +6.9%9.2%9.8 $27.04Altucher: It Looks Like My Trump prediction is coming true (Ad)New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.See Altucher’s Trump crypto prediction here 10/29/20212,170,000 shares $54.27 million +26.9%9.6%9.6 $25.01 10/15/20211,710,000 shares $37.72 million +131.6%8.5%8.7 $22.06 9/30/2021738,500 shares $19.38 million -12.0%3.7%4 $26.24 9/15/2021838,700 shares $25.83 million -7.1%4.2%6.8 $30.80 8/31/2021903,000 shares $30.70 million -7.1%4.5%6.9 $34.00 8/13/2021972,400 shares $33.17 million +3.0%4.9%7.3 $34.11 7/30/2021943,900 shares $31.53 million +45.8%4.8%6.4 $33.40 7/15/2021647,500 shares $18.96 million -8.8%2.8%4.3 $29.28 6/30/2021709,600 shares $22.13 million -2.5%3.1%5 $31.18 6/15/2021728,100 shares $23.05 million -5.0%3.2%5.1 $31.66 5/28/2021766,500 shares $24.77 million -3.3%3.3%5.2 $32.32 5/14/2021792,600 shares $24.72 million +4.2%3.2%5.3 $31.19 4/30/2021760,900 shares $25.00 million +3.9%3.4%5.2 $32.86 4/15/2021732,300 shares $25.07 million +17.9%3.3%4.8 $34.24 3/31/2021621,100 shares $18.20 million +5.2%2.8%4.1 $29.31 3/15/2021590,300 shares $16.38 million +11.2%2.4%3.7 $27.75 2/26/2021531,100 shares $17.04 million +10.0%2.5%3.6 $32.08 2/12/2021483,000 shares $17.10 million +6.2%2.3%3.2 $35.40 1/29/2021454,900 shares $16.49 million -2.7%2.4%3.4 $36.24 1/15/2021467,600 shares $20.59 million No Change2.6%3.6 $44.04 RPTX Short Interest - Frequently Asked Questions What is Repare Therapeutics' current short interest? Short interest is the volume of Repare Therapeutics shares that have been sold short but have not yet been covered or closed out. As of July 31st, investors have sold 685,500 shares of RPTX short. 2.23% of Repare Therapeutics' shares are currently sold short. Learn More on Repare Therapeutics' current short interest. What is a good short interest ratio for Repare Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPTX shares currently have a short interest ratio of 2.0. Learn More on Repare Therapeutics's short interest ratio. What is a good short interest percentage for Repare Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.23% of Repare Therapeutics' floating shares are currently sold short. Is Repare Therapeutics' short interest increasing or decreasing? Repare Therapeutics saw a increase in short interest in the month of July. As of July 31st, there was short interest totaling 685,500 shares, an increase of 22.1% from the previous total of 561,400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Repare Therapeutics' float size? Repare Therapeutics currently has issued a total of 42,960,000 shares. Some of Repare Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repare Therapeutics currently has a public float of 30,770,000 shares. How does Repare Therapeutics' short interest compare to its competitors? 2.23% of Repare Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Repare Therapeutics: Annexon, Inc. (9.94%), Neumora Therapeutics, Inc. (10.97%), Vor Biopharma Inc. (4.19%), Prima BioMed Ltd (2.92%), Alpha Teknova, Inc. (28.00%), scPharmaceuticals, Inc. (1.99%), Allogene Therapeutics, Inc. (12.88%), Sagimet Biosciences Inc. (12.47%), SOPHiA GENETICS SA (0.04%), Adherex Technologies Inc. (5.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Repare Therapeutics stock? Short selling RPTX is an investing strategy that aims to generate trading profit from Repare Therapeutics as its price is falling. RPTX shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repare Therapeutics? A short squeeze for Repare Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RPTX, which in turn drives the price of the stock up even further. How often is Repare Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPTX, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies ANNX Short Interest Data NMRA Short Interest Data VOR Short Interest Data IMMP Short Interest Data TKNO Short Interest Data SCPH Short Interest Data ALLO Short Interest Data SGMT Short Interest Data SOPH Short Interest Data FENC Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPTX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access